Belgium TED contract award · ocds-ted-773120-2024-1
Belgium – Pharmaceutical products – Facteurs de stimulation des colonies de granulocytes (G-CSF)
CHIREC awarded €18.0K to Teva Pharma Belgium for Healthcare & Medical in December 2024 — one of 47 awards this buyer has made, below its typical award size.
17 Dec 2024
Award date
€18.0K
Contract value
Buying agency
CHIREC 47 Awards
€905K Avg award
Below vs typical
Winning supplier
Teva Pharma Belgium 9 Awards
7 Buyers
€5.3M Total won
Contract description
Belgium – Pharmaceutical products – Facteurs de stimulation des colonies de granulocytes (G-CSF)
Premium
Related awards · CHIREC
47 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Tender no.SupplierAmountDateSector
- ocds-ted-122768-2026-1ZIMMER BIOMET€8.2M20 Feb 2026 Professional Services
- ocds-ted-122768-2026-2X.Nov IP€5.8M20 Feb 2026 Professional Services
- ocds-ted-35295-2025Teva Pharma Belgium€571K17 Jan 2025 Healthcare
Premium
Other wins · Teva Pharma Belgium
9 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Tender no.BuyerAmountDateSector
- ocds-ted-78562-2025-2AZ Alma€3.0M05 Feb 2025 Healthcare
- ocds-ted-284855-2024-2Onze Lieve Vrouw Van Troost v.z.w.€798K15 May 2024 Healthcare
- ocds-ted-35295-2025CHIREC€571K17 Jan 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for CHIREC and Teva Pharma Belgium — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back